Surveillance And Treatment Of Prisoners With Hepatitis C (SToP-C)
Funder
National Health and Medical Research Council
Funding Amount
$1,560,494.00
Summary
SToP-C will investigate whether a significant reduction in hepatitis C infection in NSW prisons is possible with a “treatment as prevention” strategy. It will treat prisoners for hep C infection both to improve their own health and to make onward transmission to others less likely. There is currently a lack of available effective strategies; however through delivery of simple, effective new therapies this world-first trial offers significant opportunities to reduce the burden of liver disease.
Reducing Impulsive Behaviour In Repeat Violent Offenders Using A Selective Serotonin Reuptake Inhibitor (Zoloft)
Funder
National Health and Medical Research Council
Funding Amount
$1,337,659.00
Summary
Strong evidence points to a link between poor impulse control (impulsivity) and violent crime. Impulsivity has been shown to be associated with reduced levels of the neurotransmitter serotonin. In studies of impulsive individuals, selective serotonin reuptake inhibitors (SSRIs) have reduced impulsive aggression but there has been no systematic study of the benefits of SSRIs for violent offenders at risk of reoffending. This research will investigate whether SSRIs can reduce repeat violent offend ....Strong evidence points to a link between poor impulse control (impulsivity) and violent crime. Impulsivity has been shown to be associated with reduced levels of the neurotransmitter serotonin. In studies of impulsive individuals, selective serotonin reuptake inhibitors (SSRIs) have reduced impulsive aggression but there has been no systematic study of the benefits of SSRIs for violent offenders at risk of reoffending. This research will investigate whether SSRIs can reduce repeat violent offending.Read moreRead less
Prevention And Treatment Of Viral Hepatitis Amongst Prisoners
Funder
National Health and Medical Research Council
Funding Amount
$1,102,510.00
Summary
Hepatitis B and C infection rates remain very high in some Australian populations, notably prisoners. As this group cycles frequently back to the general community, prevention of transmission is critical. Antiviral treatment uptake remains very low in Australia, yet the prison environment offers a unique opportunity to address this. This project aims to assess effectiveness of existing prevention strategies, guide new control measures, and to evaluate a novel nurse-led model for treatment.